Cardio-oncology practice manual: (Record no. 40062)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03739nam a22002537a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | KENaKMTC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250226131718.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 250226b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780323681353 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780323681360 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0323681360 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | DLC |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC681.H47 2023 |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Herrmann joerg |
| Relator term | Author |
| 245 ## - TITLE STATEMENT | |
| Title | Cardio-oncology practice manual: |
| Remainder of title | Acompanion to braunwald's heart disease/ |
| Statement of responsibility, etc | joerg herrmann |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc | Philadelphia: |
| Name of publisher, distributor, etc | Elsevier, |
| Date of publication, distribution, etc | c2023 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | xx,518pages: |
| Other physical details | color illustrations; |
| Dimensions | 23cm |
| 500 ## - GENERAL NOTE | |
| General note | Includes index |
| 505 ## - FORMATTED CONTENTS NOTE | |
| Formatted contents note | CONTENTS<br/>1. The Cardio-Oncology Clinic:g0als,scope and focus of practice-- Part I. Cardiovascular Disease Management Before Cancer Treatment-- Section A. The A-to-Z Before Therapy--<br/> 2. Key Points of Cardio-Oncology Evaluation Before Cancer Therapy --<br/>3. Chemotherapeutic Risks Before Cancer Therapy --<br/>4. Radiation Therapy Risks Before Cancer Therapy --<br/>5. Bone Marrow Transplantation Risks Before Cancer Therapy --<br/>6. Surgical Risks Before Cancer Therapy Section B. Cardiovascular Disease Prevention in Cancer Patients --<br/>7. Cardiomyopathy/Heart Failure Prevention Before Cancer Therapy --<br/>8. Vascular Disease Prevention Before Cancer Therapy-- <br/>9. Thromboembolic Disease Prevention Before Cancer Therapy --<br/>10. Arrhythmia Prevention and Device Management Before Cancer Therapy-- <br/>11. Hypertension and Renal Disease Prevention Before Cancer Therapy-- <br/>12. Pulmonary Disease Prevention Before Cancer Therapy --<br/>13. Cardiopulmonary Exercise for Prevention Before Cancer Therapy Part II. Cardiovascular Disease Management During Cancer Treatment-- Section C. The A-to-Z Through Therapy --<br/>14. Key Points of Cardio-Oncology Evaluation During Cancer Therapy --<br/>15. Cardiomyopathy/Heart Failure Myocarditis, and Takotsubo's During Cancer Therapy --<br/>16. Structural Heart Disease --<br/>17. Vascular Disease --<br/>18. Thromboembolic Disease --<br/>19. Arrhythmia, QTc Prolongation, and Device Management --<br/>20. Hypertension and Renal Disease --<br/>21. Pulmonary Disease-- <br/>22. Cardiovascular Imaging Part III. Cardiovascular Disease Management After Cancer Treatment Section D. The A-to-Z After Therapy --<br/>23. Key Points of Cardio-Oncology Evaluation After Cancer Therapy --<br/>24. Cancer Survivorship and Co-Morbidity Disease Risk --<br/>25. Long-Term Complications of Chemotherapy --<br/>26. Long-Term Complications of Radiation Therapy Section E. Cardiovascular Disease in Cancer Survivors --<br/>27. Cardiomyopathy/Heart Failure Prevention and Management --<br/>28. Structureal Heart Disease Prevention and Management --<br/>29. Vascular Disease Prevention and Management-- <br/>30. Thromboembolic Disease Prevention and Management --<br/>31. Arrhythmia Prevention and Management --<br/>32. Hypertension and Renal Failure Prevention and Management --<br/>33. Pulmonary Disease Prevention and Management --<br/>34. Cardiopulmonary Rehabilitation Section F. Cardiovascular Disease Management in Specific Malignant Diseases --<br/>35. Breast Cancer 36. Uterine, Ovary, and Cervical Cancer --<br/>37. Prostate and Testicular Cancer --<br/>38. Renal and Urinary Bladder Cancer --<br/>39. Lung Cancer 40. Colorectal Cancer --<br/>41. Esophageal and Gastric Cancer --<br/>42. Hepatobiliary Carcinomas --<br/>43. Pancreatic Cancer --<br/>44. Melanoma --<br/>45. Head-and-Neck Cancers --<br/>46. Thyroid cancer 47. Glioblastoma --<br/>48. Bone and Soft Tissue Sarcomas --<br/>49. Leukemias 50. Lymphomas --<br/>51. Multiple Myeloma and Cardiac Amyloidosis --<br/>52. Carcinoid 53. Cardiac Masses Part IV. Cancer Drugs <br/>54. Cancer Therapeutic Drug Guide.<br/> |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Cancer Traitement Complications et séquelles |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Heart Diseases |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Cœur Maladies Étiologie |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Library of Congress Classification |
| Koha item type | Books |
| Intials | MA |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Library of Congress Classification | KMTC:MANDERA CAMPUS | KMTC:MANDERA CAMPUS | General Stacks | 14/10/2024 | RC681.H47 2023 | MDR/004 | 26/02/2025 | Books |